** Shares of healthcare products distributor Henry Schein HSIC.O rise 6.2% to $73.09
** Activist investor Ananym Capital Management is urging Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business
** Ananym argues that Schein needs new board members and ultimately a new CEO to tackle spending, according to a Reuters report
** Ananym says medical distribution business sale could increase stock price by 20%
** Including session's move, stock down 2.1% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。